よむ、つかう、まなぶ。
【参考資料３】【英版R4.1.17】Nippon AMR One Health Report (NAOR) 2020 (17 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_23261.html |
| 出典情報 | 国際的に脅威となる感染症対策関係閣僚会議 薬剤耐性ワンヘルス動向調査検討会（第9回 1／17）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
ⅰ. Staphylococcus aureus
Table 7. The proportion (%) of antimicrobial resistance in Staphylococcus aureus strains
BP
0.25
PCG
MPIPC
4
CFX
8
CEZ
32
GM
16
EM
8
CLDM
4
MINO
16
VCM
16
TEIC
32
LVFX
4
LZD
8
DAP
2
2018
75.4
(287,805)
47.8
(266,047)
46.1
(57,604)
20.7
(360,772)
30.4
(345,964)
51.7
(325,918)
22.0
(340,953)
12.2
(377,507)
0.0
(374,982)
<0.05
(336,502)
2019
75.1
(295,031)
47.7
(265,763)
46.0
(64,239)
19.7
(366,803)
28.9
(350,425)
51.2
(329,090)
20.4
(350,136)
10.5
(385,264)
0.0
(382,254)
＜0.05
(340,855)
51.7
(368,676)
＜0.05
(294,735)
0.3
(98,366)
50.4
(358,941)
<0.05
(286,366)
0.3
(72,401)
The unit of BP is μg/mL.
Figures in parentheses indicate the number of bacterial strains that were tested for antimicrobial susceptibility.
*Data collection began in 2018.
-: Not under surveillance
Table 8. The propotion (%) of antimicrobial resistance in methicillin-susceptible Staphylococcus aureus
(MSSA)
PCG
BP
0.25
2011
61.1
(68,839)
0.3
(77,483)
2012
60.1
(75,025)
<0.05
(84,520)
2013
59.0
(82,477)
0.2
(93,945)
2014
57.7
(86,314)
0.2
(103,603)
2015
56.2
(119,343)
0.1
(146,254)
2016
55.0
(126,394)
<0.05
(157,917)
2017
53.9
(129,943)
<0.05
(161,831)
2018
52.9
(135,360)
<0.05
(164,909)
CEZ
32
CVA/
AMPC
IPM
4/8
0.3
(11,696)
0.3
(74,636)
0.1
(9,466)
<0.05
(80,472)
0.2
(11,230)
0.2
(88,422)
0.2
(11,666)
0.2
(95,951)
0.1
(19,163)
<0.05
(136,878)
0.1
(21,783)
<0.05
(146,433)
0.1
(24,713)
<0.05
(149,014)
0.1
(26,376)
<0.05
(149,454)
22.7
23.4
24.0
23.8
22.9
23.3
(72,738)
(79,683)
(88,528)
(96,829)
(136,763)
(146,280)
CLDM
4
3.4
3.1
3.2
2.8
2.8
2.9
(67,523)
(74,387)
(83,914)
(93,467)
(136,292)
(148,439)
MINO
16
0.7
0.6
0.5
0.6
0.6
0.5
(77,872)
(84,595)
(94,425)
(104,145)
(151,493)
(163,214)
LVFX
4
9.3
10.2
10.6
10.7
11.6
12.3
(73,163)
(79,857)
(89,641)
(99,898)
(144,083)
(154,868)
The unit of BP is μg/mL.
Figures in parentheses indicate the number of bacterial strains that were tested for antimicrobial susceptibility.
23.5
(148,795)
2.9
(151,841)
0.6
(167,178)
13.1
(159,066)
23.1
(150,809)
2.7
(155,141)
0.6
(169,953)
13.8
(161,691)
EM
16
8
16
2019
52.1
(138,818)
＜0.05
(167,084)
0.1
(25,258)
＜0.05
(150,811)
22.7
(151,577)
2.9
(157,700)
0.5
(171,857)
14.7
(164,665)
Table 7. The proportion (%) of antimicrobial resistance in Staphylococcus aureus strains
BP
0.25
PCG
MPIPC
4
CFX
8
CEZ
32
GM
16
EM
8
CLDM
4
MINO
16
VCM
16
TEIC
32
LVFX
4
LZD
8
DAP
2
2018
75.4
(287,805)
47.8
(266,047)
46.1
(57,604)
20.7
(360,772)
30.4
(345,964)
51.7
(325,918)
22.0
(340,953)
12.2
(377,507)
0.0
(374,982)
<0.05
(336,502)
2019
75.1
(295,031)
47.7
(265,763)
46.0
(64,239)
19.7
(366,803)
28.9
(350,425)
51.2
(329,090)
20.4
(350,136)
10.5
(385,264)
0.0
(382,254)
＜0.05
(340,855)
51.7
(368,676)
＜0.05
(294,735)
0.3
(98,366)
50.4
(358,941)
<0.05
(286,366)
0.3
(72,401)
The unit of BP is μg/mL.
Figures in parentheses indicate the number of bacterial strains that were tested for antimicrobial susceptibility.
*Data collection began in 2018.
-: Not under surveillance
Table 8. The propotion (%) of antimicrobial resistance in methicillin-susceptible Staphylococcus aureus
(MSSA)
PCG
BP
0.25
2011
61.1
(68,839)
0.3
(77,483)
2012
60.1
(75,025)
<0.05
(84,520)
2013
59.0
(82,477)
0.2
(93,945)
2014
57.7
(86,314)
0.2
(103,603)
2015
56.2
(119,343)
0.1
(146,254)
2016
55.0
(126,394)
<0.05
(157,917)
2017
53.9
(129,943)
<0.05
(161,831)
2018
52.9
(135,360)
<0.05
(164,909)
CEZ
32
CVA/
AMPC
IPM
4/8
0.3
(11,696)
0.3
(74,636)
0.1
(9,466)
<0.05
(80,472)
0.2
(11,230)
0.2
(88,422)
0.2
(11,666)
0.2
(95,951)
0.1
(19,163)
<0.05
(136,878)
0.1
(21,783)
<0.05
(146,433)
0.1
(24,713)
<0.05
(149,014)
0.1
(26,376)
<0.05
(149,454)
22.7
23.4
24.0
23.8
22.9
23.3
(72,738)
(79,683)
(88,528)
(96,829)
(136,763)
(146,280)
CLDM
4
3.4
3.1
3.2
2.8
2.8
2.9
(67,523)
(74,387)
(83,914)
(93,467)
(136,292)
(148,439)
MINO
16
0.7
0.6
0.5
0.6
0.6
0.5
(77,872)
(84,595)
(94,425)
(104,145)
(151,493)
(163,214)
LVFX
4
9.3
10.2
10.6
10.7
11.6
12.3
(73,163)
(79,857)
(89,641)
(99,898)
(144,083)
(154,868)
The unit of BP is μg/mL.
Figures in parentheses indicate the number of bacterial strains that were tested for antimicrobial susceptibility.
23.5
(148,795)
2.9
(151,841)
0.6
(167,178)
13.1
(159,066)
23.1
(150,809)
2.7
(155,141)
0.6
(169,953)
13.8
(161,691)
EM
16
8
16
2019
52.1
(138,818)
＜0.05
(167,084)
0.1
(25,258)
＜0.05
(150,811)
22.7
(151,577)
2.9
(157,700)
0.5
(171,857)
14.7
(164,665)